CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation

  1. Francesco Andreata
  2. Marc Clément
  3. Robert A Benson
  4. Juliette Hadchouel
  5. Emanuele Procopio
  6. Guillaume Even
  7. Julie Vorbe
  8. Samira Benadda
  9. Véronique Ollivier
  10. Benoit Ho-Tin-Noe
  11. Marie Le Borgne
  12. Pasquale Maffia
  13. Antonino Nicoletti
  14. Giuseppina Caligiuri  Is a corresponding author
  1. Laboratory for Vascular Translational Science, France
  2. University of Glasgow, United Kingdom
  3. Université Paris Cité, INSERM, France
  4. Université de Paris, INSERM U1149, CNRS ERL8252, France

Abstract

Effective neutrophil migration to sites of inflammation is crucial for host immunity. A coordinated cascade of steps allows intravascular leukocytes to counteract the shear stress, transmigrate through the endothelial layer and move towards the extravascular, static environment. Those events are tightly orchestrated by integrins but, while the molecular mechanisms leading to their activation have been characterized, the regulatory pathways promoting their detachment remain elusive. In light of this, it has long been known that Platelet-Endothelial Cell Adhesion Molecule (Pecam1, also known as CD31) deficiency blocks leukocyte transmigration at the level of the outer vessel wall, yet the associated cellular defects are controversial. In this study, we combined an unbiased proteomic study with in vitro and in vivo single-cell tracking in mice to study the dynamics and role of CD31 during neutrophil migration. We found that CD31 localizes to the uropod of migrating neutrophils along with closed β2-integrin and is required for essential neutrophil actin/integrin polarization. Accordingly, the uropod of Pecam1-/- neutrophils is unable to detach from the extracellular matrix, while antagonizing integrin binding to extracellular matrix components rescues this in vivo migratory defect. Conversely, we showed that sustaining CD31 co-signaling actively favors uropod detachment and effective migration of extravasated neutrophils to sites of inflammation in vivo. Altogether, our results suggest that CD31 acts as a molecular rheostat controlling integrin-mediated adhesion at the uropod of egressed neutrophils thereby triggering their detachment from the outer vessel wall to reach the inflammatory sites.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-5.

Article and author information

Author details

  1. Francesco Andreata

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  2. Marc Clément

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6479-8360
  3. Robert A Benson

    Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    No competing interests declared.
  4. Juliette Hadchouel

    INSERM UMR_S1155, Université Paris Cité, INSERM, Paris, France
    Competing interests
    No competing interests declared.
  5. Emanuele Procopio

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  6. Guillaume Even

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  7. Julie Vorbe

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  8. Samira Benadda

    Centre de recherche sur l'inflammation, Université de Paris, INSERM U1149, CNRS ERL8252, Paris, France
    Competing interests
    No competing interests declared.
  9. Véronique Ollivier

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  10. Benoit Ho-Tin-Noe

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  11. Marie Le Borgne

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3439-4867
  12. Pasquale Maffia

    Institute of infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3926-4225
  13. Antonino Nicoletti

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    Antonino Nicoletti, is an inventorn patents filed (Improved CD31 peptides" PCT/EP2013/062806) related to the work presented in this manuscript. No other potential conflicts of interest relevant to this article exist.".
  14. Giuseppina Caligiuri

    Laboratory for Vascular Translational Science, Paris, France
    For correspondence
    giuseppina.caligiuri@inserm.fr
    Competing interests
    Giuseppina Caligiuri, is an inventor on patents filed (Improved CD31 peptides" PCT/EP2013/062806) related to the work presented in this manuscript. No other potential conflicts of interest relevant to this article exist.".
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4973-2205

Funding

MSDAVENIR (SAVE-Brain)

  • Antonino Nicoletti

Agence Nationale de la Recherche (10-LABX-0017 Inflamex"")

  • Marc Clément

Agence Nationale de la Recherche (DS0404-16-RHUS-00010 iVASC"")

  • Giuseppina Caligiuri

Engineering and Physical Sciences Research Council (grant EP/L014165/1)

  • Pasquale Maffia

British Heart Foundation (PG/19/84/34771)

  • Pasquale Maffia

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All the investigations were conformed to the directive 2010/63/EU of the European Parliament and formal approval was granted by the local Animal Ethics Committee (Comité d'étique Bichat-Debré, Paris, France).

Copyright

© 2023, Andreata et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,069
    views
  • 126
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Francesco Andreata
  2. Marc Clément
  3. Robert A Benson
  4. Juliette Hadchouel
  5. Emanuele Procopio
  6. Guillaume Even
  7. Julie Vorbe
  8. Samira Benadda
  9. Véronique Ollivier
  10. Benoit Ho-Tin-Noe
  11. Marie Le Borgne
  12. Pasquale Maffia
  13. Antonino Nicoletti
  14. Giuseppina Caligiuri
(2023)
CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation
eLife 12:e84752.
https://doi.org/10.7554/eLife.84752

Share this article

https://doi.org/10.7554/eLife.84752

Further reading

    1. Cell Biology
    2. Developmental Biology
    Sofía Suárez Freire, Sebastián Perez-Pandolfo ... Mariana Melani
    Research Article

    Eukaryotic cells depend on exocytosis to direct intracellularly synthesized material toward the extracellular space or the plasma membrane, so exocytosis constitutes a basic function for cellular homeostasis and communication between cells. The secretory pathway includes biogenesis of secretory granules (SGs), their maturation and fusion with the plasma membrane (exocytosis), resulting in release of SG content to the extracellular space. The larval salivary gland of Drosophila melanogaster is an excellent model for studying exocytosis. This gland synthesizes mucins that are packaged in SGs that sprout from the trans-Golgi network and then undergo a maturation process that involves homotypic fusion, condensation, and acidification. Finally, mature SGs are directed to the apical domain of the plasma membrane with which they fuse, releasing their content into the gland lumen. The exocyst is a hetero-octameric complex that participates in tethering of vesicles to the plasma membrane during constitutive exocytosis. By precise temperature-dependent gradual activation of the Gal4-UAS expression system, we have induced different levels of silencing of exocyst complex subunits, and identified three temporarily distinctive steps of the regulated exocytic pathway where the exocyst is critically required: SG biogenesis, SG maturation, and SG exocytosis. Our results shed light on previously unidentified functions of the exocyst along the exocytic pathway. We propose that the exocyst acts as a general tethering factor in various steps of this cellular process.

    1. Cell Biology
    Fatima Tleiss, Martina Montanari ... C Leopold Kurz
    Research Article

    Multiple gut antimicrobial mechanisms are coordinated in space and time to efficiently fight foodborne pathogens. In Drosophila melanogaster, production of reactive oxygen species (ROS) and antimicrobial peptides (AMPs) together with intestinal cell renewal play a key role in eliminating gut microbes. A complementary mechanism would be to isolate and treat pathogenic bacteria while allowing colonization by commensals. Using real-time imaging to follow the fate of ingested bacteria, we demonstrate that while commensal Lactiplantibacillus plantarum freely circulate within the intestinal lumen, pathogenic strains such as Erwinia carotovora or Bacillus thuringiensis, are blocked in the anterior midgut where they are rapidly eliminated by antimicrobial peptides. This sequestration of pathogenic bacteria in the anterior midgut requires the Duox enzyme in enterocytes, and both TrpA1 and Dh31 in enteroendocrine cells. Supplementing larval food with hCGRP, the human homolog of Dh31, is sufficient to block the bacteria, suggesting the existence of a conserved mechanism. While the immune deficiency (IMD) pathway is essential for eliminating the trapped bacteria, it is dispensable for the blockage. Genetic manipulations impairing bacterial compartmentalization result in abnormal colonization of posterior midgut regions by pathogenic bacteria. Despite a functional IMD pathway, this ectopic colonization leads to bacterial proliferation and larval death, demonstrating the critical role of bacteria anterior sequestration in larval defense. Our study reveals a temporal orchestration during which pathogenic bacteria, but not innocuous, are confined in the anterior part of the midgut in which they are eliminated in an IMD-pathway-dependent manner.